Histone cluster 2 family member, a protein intricately linked to chromatin structure and gene regulation, can be effectively inhibited by a variety of chemicals that target specific molecular mechanisms. Among these inhibitors, Vorinostat (SAHA) has been shown to play a crucial role. Vorinostat modulates histone acetylation patterns by inhibiting HDAC enzymes, thereby influencing the protein's function in chromatin remodeling and gene expression regulation. This chemical, by altering the acetylation status of histones, can impact the accessibility of the DNA, ultimately affecting the transcriptional activity of genes associated with histone cluster 2 family member.
In addition to HDAC inhibitors, compounds like 5-Azacytidine (CAS Number 320-67-2) target DNA methyltransferases, key players in DNA methylation processes. 5-Azacytidine can demethylate DNA, thus altering the epigenetic landscape and potentially affecting the regulation of histone cluster 2 family member. By decreasing DNA methylation at specific regulatory regions, this inhibitor can modulate the gene expression patterns associated with the protein. It is important to note that these inhibitors, while providing valuable insights into the modulation of histone cluster 2 family member, require rigorous experimental validation to fully understand their precise roles and potential indirect effects on this multifaceted protein. These chemicals, each with its distinct mechanism of action, underscore the complexity of regulating histone cluster 2 family member. While Vorinostat and 5-Azacytidine offer promising avenues for understanding the protein's functions in chromatin dynamics and gene expression, it is essential to recognize that the inhibition of this protein is a complex interplay of epigenetic modifications and chromatin remodeling. Researchers must conduct further investigations to elucidate the exact impact of these inhibitors on histone cluster 2 family member in various cellular contexts, unraveling the intricacies of its regulatory role in gene expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, also known as SAHA, is an FDA-approved histone deacetylase (HDAC) inhibitor. It can indirectly impact the function of histone cluster 2 family member by altering histone acetylation and chromatin structure. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor. It can demethylate DNA, potentially influencing the epigenetic regulation of histone cluster 2 family member and its gene expression. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
Ruxolitinib is a JAK2 inhibitor. It can block the JAK2 signaling pathway, which may indirectly affect the function of histone cluster 2 family member if it is involved in JAK2-mediated signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. It can inhibit the PI3K pathway, which can have downstream effects on various cellular processes, potentially impacting histone cluster 2 family member's function if it is linked to this pathway. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine is a DNA methyltransferase inhibitor. It can demethylate DNA, which might influence the epigenetic regulation of histone cluster 2 family member and its gene expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is a topoisomerase inhibitor. It can inhibit topoisomerase enzymes involved in DNA replication and repair processes. This could indirectly impact histone cluster 2 family member's role in chromatin dynamics and gene regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. It can block the mTOR signaling pathway, which may have downstream effects on various cellular processes, potentially influencing the function of histone cluster 2 family member if it is connected to mTOR-mediated pathways. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is an RNA polymerase inhibitor. It can block RNA polymerase activity, indirectly affecting transcription processes that involve the protein. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 is a BET bromodomain inhibitor. It specifically targets bromodomain-containing proteins and may influence the chromatin structure and gene expression, potentially inhibiting the function of histone cluster 2 family member. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB431542 is a TGF-β receptor inhibitor. It can block TGF-β signaling pathways, which may indirectly affect histone cluster 2 family member if it is involved in TGF-β-mediated signaling. | ||||||